Find My Journal

CC

C. Calvet

Bristol-Myers Squibb (United States) US

47

Publications

779

Citations

10

H-Index

10

i10-Index

0.5

2yr Mean Cite

-

Cite/Paper

Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Publications

46 total

OA03.06 Repotrectinib in Patients with ROS1 Fusion-positive (ROS1+) NSCLC: Update from the Pivotal Phase 1/2 TRIDENT-1 Trial PDF

Byoung Chul Cho, D. Ross Camidge, W. Marston Linehan, Seung‐Whan Kim, B. Solomon et al. - Journal of Thoracic Oncology, 2023

Cited by 9 OpenAlex

Effectiveness and safety of nivolumab in the treatment of lung cancer patients in France: preliminary results from the real-world EVIDENS study PDF

Fabrice Barlési, A. Dixmier, D. Debieuvre, C. Raspaud, J.B. Auliac et al. - OncoImmunology, 2020

Cited by 38 OpenAlex

Nivolumab treatment in advanced non-small cell lung cancer: real-world long-term outcomes within overall and special populations (the UNIVOC study) PDF

Jean‐Baptiste Assié, R. Corre, Matteo Giaj Levra, C. Calvet, Anne-Françoise Gaudin et al. - Therapeutic Advances in Medical Oncology, 2020

Cited by 19 OpenAlex

Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysis PDF

Matteo Giaj Levra, François-Emery Cotté, R. Corre, C. Calvet, Anne-Françoise Gaudin et al. - Lung Cancer, 2019

Cited by 124 OpenAlex

MA07.06 Immunotherapy Re-Challenge After Nivolumab Treatment in Advanced Non-Small Cell Lung Cancer in French Real-World Setting PDF

Matteo Giaj Levra, François-Emery Cotté, R. Corre, C. Calvet, B. Jouaneton et al. - Journal of Thoracic Oncology, 2019

Cited by 5 OpenAlex

Health-related quality of life (HRQoL) of non-small cell lung cancer (NSCLC) patients treated with nivolumab in real-life: The EVIDENS study PDF

M. Pérol, A. Dixmier, Fabrice Barlési, D. Debieuvre, C. Raspaud et al. - Annals of Oncology, 2019

Cited by 5 OpenAlex

The promising alliance of anti-cancer electrochemotherapy with immunotherapy PDF

C. Calvet, Lluis M. Mir - Cancer and Metastasis Reviews, 2016

Cited by 121 OpenAlex

Earth2Observe/Water-Resource-Reanalysis-V1: Revised Release OA

Jaap Schellekens, Emanuel Dutra, Gianpaulo Balsamo, Albert I. J. M. van Dijk, Frederiek Sperna Weiland et al. - Figshare, 2016

Cited by 10 OpenAlex

Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells PDF

C. Calvet, Delphine Famin, Franck M. André, Lluis M. Mir - OncoImmunology, 2014

Cited by 217 OpenAlex

The Culture of Cancer Cell Lines as Tumorspheres Does Not Systematically Result in Cancer Stem Cell Enrichment PDF

C. Calvet, Franck M. André, Lluis M. Mir - PLoS ONE, 2014

Cited by 76 OpenAlex

Research Topics

Lung Cancer Treatments and Mutations (20) Cancer Immunotherapy and Biomarkers (19) Economic and Financial Impacts of Cancer (9) Microbial Inactivation Methods (7) Transgenic Plants and Applications (7)

Affiliations

Université Paris-Sud

FR 2016 - 2014

Centre National de la Recherche Scientifique

FR 2016 - 2014

Bristol-Myers Squibb (Germany)

DE 2025 - 2020

Palo Alto University

US 2015 - 2015

Université Paris-Saclay

FR 2020 - 2014

External Profiles

OpenAlex Profile Search Semantic Scholar Google Scholar

Share Profile

Back to Researchers